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efficient π–π stacking with a binding affinity of 106–107 
M−1. Under porphyrin excess, PtTMPyP4 aggregates using 
Tel22 as a template; the aggregates reach maximum size 
at [PtTMPyP4]/[Tel22] ~8 and dissolve at [PtTMPyP4]/
[Tel22] ≤ 2. FRET assays reveal that both porphyrins are 
excellent stabilizers of human telomeric DNA, with stabi-
lization temperature of 30.7 ± 0.6 °C for PtTMPyP4 and 
30.9 ± 0.4 °C for PdTMPyP4 at [PtTMPyP4]/[Tel22] = 2 
in K+ buffer, values significantly higher as compared to 
those for TMPyP4. The porphyrins display modest selectiv-
ity for quadruplex vs. duplex DNA, with selectivity ratios 
of 150 and 330 for Pt- and PdTMPyP4, respectively. This 
selectivity was confirmed by observed ‘light switch’ effect: 
fluorescence of PtTMPyP4 increases significantly in the 
presence of a variety of DNA secondary structures, yet the 
strongest effect is produced by quadruplex DNA.
Graphical abstract 
Keywords G-quadruplex DNA · Metalloporphyrin · 
Light switch effect · Fluorescence · Human telomeric DNA
Abbreviations
CT  Calf thymus DNA
GQ  Guanine quadruplex DNA
PtTMPyP4  Pt(II) 5,10,15,20-tetrakis (N-methyl-4-pyri-
dyl) porphyrin
Abstract G-quadruplexes are non-canonical DNA struc-
tures formed by guanine-rich DNA sequences that are 
implicated in cancer and aging. Understanding how small 
molecule ligands interact with quadruplexes is essential 
both to the development of novel anticancer therapeu-
tics and to the design of new quadruplex-selective probes 
needed for elucidation of quadruplex biological functions. 
In this work, UV–visible, fluorescence, and circular dichro-
ism spectroscopies, fluorescence resonance energy trans-
fer (FRET) melting assays, and resonance light scattering 
were used to investigate how the Pt(II) and Pd(II) deriva-
tives of the well-studied 5,10,15,20-tetrakis(N-methyl-
4-pyridyl)porphyrin (TMPyP4) interact with quadruplexes 
formed by the human telomeric DNA, Tel22, and by the 
G-rich sequences from oncogene promoters. Our results 
suggest that Pt- and PdTMPyP4 interact with Tel22 via 
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PdTMPyP4  Pd(II) 5,10,15,20-tetrakis (N-methyl-4-pyri-
dyl) porphyrin
Tel22  Human telomeric DNA repeat model 
sequence
Introduction
In addition to a Watson–Crick duplex, DNA can exist in a 
variety of non-canonical secondary structures, including 
G-quadruplex DNA [1]. G-quadruplexes (GQs) are formed 
by π–π stacking between G-quartets composed of four 
guanines connected via Hoogsteen hydrogen bonding and 
stabilized by a coordinating cation (Fig. 1a, b). Sequences 
with quadruplex-forming potential are found throughout the 
human genome, notably at telomeres [2] and at the promot-
ers of many oncogenes [3–5]. GQs may play an important 
role in a variety of biological processes such as telomere 
maintenance, transcription, translation, replication, genome 
stability, and DNA repair [6–9]. More importantly, the exist-
ence of GQs in living cells was recently validated by their 
direct visualization [10–12]. G-rich DNA is now established 
as a potent therapeutic target, especially for cancer.
Telomeres are present at the end of eukaryotic chromo-
somes and protect them from degradation and end-fusion. 
They comprise repetitive G-rich sequences, TTAGGG in 
humans and other vertebrates. Realization that human telo-
meric DNA has a potential to fold into a quadruplex struc-
ture brought it to the forefront of drug discovery efforts. 
Formation of quadruplexes in telomeres leads to inhibition 
of telomerase, the enzyme responsible for telomere main-
tenance and, hence, immortality of cancer cells. The most 
widely studied model of human telomeric DNA is Tel22, 
AGGG(TTAGGG)3, whose structure, folding, and stability 
have been researched extensively [13]. This oligonucleotide 
or its variants form a unimolecular antiparallel GQ in Na+ 
buffer [14], at least two different mixed-hybrid structures 
in K+ buffers [15–17], and a parallel GQ when crystallized 
in the presence of K+ [18] or in solution under dehydrating 
conditions (e.g., PEG or ethanol) [19].
Structure and stability of quadruplexes and, hence, their 
biological functions can be altered by the presence of small 
molecule ligands [20–23]. Ligands induce quadruplex for-
mation or stabilize existing quadruplexes in telomeres and 
in oncogene promoters, leading to the inhibition of telomer-
ase and to an alteration of oncogene expressions. Selective 
interactions between ligands and quadruplex DNA consti-
tute a novel anticancer methodology. Over the last 18 years, 
a number of drug-discovery research programs have pro-
duced successful GQ-selective ligands [22, 24–27], many 
Fig. 1  a G-tetrad consists of 
four guanine residues associated 
together through Hoogsteen 
hydrogen bonding and stabi-
lized by a monovalent cation.  
b Schematic representation of 
a monomolecular mixed-hybrid 
GQ (left), bimolecular antiparal-
lel GQ (middle) and tetras-
tranded parallel GQ (right).  
c Structures of PtTMPyP4 and 
PdTMPyP4
a
b
c
N
N
N N
N N
N N
M
M = Pt(II) or Pd(II)
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of which have been shown to inhibit tumors in vitro and 
in vivo. Our work here focuses on two metal derivatives 
of the widely studied ligand 5,10,15,20-tetrakis(N-methyl-
4-pyridyl) porphyrin, TMPyP4, with Pt(II) and Pd(II) 
(Fig. 1c). TMPyP4 was shown to inhibit telomerase [28–
30] and downregulate expression of oncogenes c-myc [3] 
and Kras [31] through binding, stabilization, and structural 
alteration of quadruplexes. Cellular uptake and localization 
studies demonstrate that TMPyP4 and its derivatives can 
accumulate rapidly in nuclei of normal and tumor cells [32] 
at levels sufficient for tumor growth arrest yet non-toxic to 
somatic cells [30] without appreciable membrane binding. 
In addition, TMPyP4 is water soluble and brightly colored, 
which facilitates its administration and study. Although 
TMPyP4 is an excellent quadruplex stabilizer, it suffers 
from modest selectivity for GQ vs. duplex DNA [33]. In 
spite of this limitation, TMPyP4 is still widely used by 
researchers in the quadruplex field, with over 110 publica-
tions in the last five years (according to http://www.gopub-
med.com).
In order to utilize TMPyP4′s excellent quadruplex sta-
bilizing ability, improve its GQ-selectivity, and confer 
additional useful properties such as fluorescence, a vari-
ety of modifications to TMPyP4 were reported [24, 25]; 
here we focus on metalation. In principle, a variety of 
metals can be placed in the center of TMPyP4; many of 
these metal derivatives were shown to bind quadruplexes, 
notably those with Cu(II), Zn(II), Ni(II), Mn(III), In(III), 
and Co(III) [25, 34–40]. Metalation of TMPyP4 changes 
its electronic structure, leading to drastic changes in its 
ability to bind GQ DNA and inhibit telomerase [25]. The 
presence of a metal decreases the electron density of the 
ligand’s aromatic system, increasing its π–π stacking abil-
ity with the terminal G-tetrad, leading to stronger ligand–
GQ interactions. In addition, if a metal coordinated to a 
ligand is placed above the center of the G-tetrad, it can 
replace the monovalent ion found there, strengthening 
ligand–GQ interactions, due to electrostatic effect. This 
mode of binding was observed between the human telom-
eric DNA and Ni(II) or Cu(II) Salfen ligands [41]. Finally, 
central metal substitution into TMPyP4 may introduce 
axial ligands to the metal, as is the case for Zn(II) (one 
axial water) or Mn(III) and Co(III) (two axial water mol-
ecules), further affecting its quadruplex binding abilities 
and importantly, the selectivity.
The goal of this report was to investigate how PtTMPyP4 
and PdTMPyP4 interact with quadruplex structures and how 
these interactions differ from those with the parent porphy-
rin, TMPyP4. This comparison will allow us to highlight the 
specific roles that metal ions may play in the interactions 
between ligands and quadruplexes. Both porphyrins adopt 
square planar geometry similar to that of TMPyP4; they 
are water soluble, intensely colored and fluorescent, pro-
viding convenient handles on monitoring their interactions 
with DNA. PtTMPyP4 was reported to inhibit telomerase 
(although less efficiently as compared to TMPyP4) [25, 29] 
and act as photosensitizer in photodynamic therapy [42]. We 
performed UV–Vis, CD, and fluorescence titrations, FRET 
melting assay and resonance light scattering studies using 
quadruplex structures formed by human telomeric DNA 
and DNA from a variety of biologically relevant oncogene 
promoters. In many respects, both Pt(II) and Pd(II) metal-
lated derivatives of TMPyP4 resemble their parent porphy-
rin molecule but display significantly stronger quadruplex 
stabilization and higher fluorescence. Our findings have 
significant implication for understanding the exact role that 
metals play in ligand binding to quadruplex DNA.
Materials and methods
Porphyrins, oligonucelotides, and buffers
PtTMPyP4 was a generous gift from Dr. Robert F. Pas-
ternack, Swarthmore College, and PdTMPyP4 was pur-
chased from Frontier Scientific (Logan, UT, USA). Por-
phyrin stock solutions were prepared in double-distilled 
water (ddH2O) at 1.0–1.4 mM concentrations and stored at 
−20 °C in the dark. Porphyrin concentrations were deter-
mined via UV–Vis spectroscopy, using ε401 = 1.72 × 105 
M−1cm−1 for PtTMPyP4 [43] and ε418 = 1.68 × 105 
M−1cm−1 for PdTMPyP4 [44].
Oligonucleotides were purchased from Midland Certi-
fied Reagent Company (Midland, TX, USA) or Eurogen-
tec (Liège, Belgium); calf thymus (CT) DNA was obtained 
from Sigma-Aldrich; the fluorescently labeled oligonucleo-
tide 5′-6-FAM-GGG(TTAGGG)3-Dabcyl-3′ (F21D) was 
purchased from IDT (Coralville, IA, USA). All oligonu-
cleotides were dissolved at 1.0 mM strand concentration, 
while F21D was dissolved at 0.1 mM in ddH2O and stored 
at −80 °C. To induce the formation of the most thermo-
dynamically stable GQs, oligonucleotides were heated 
at 90 °C for 5 min, cooled to room temperature over the 
course of 3–4 h, and incubated overnight at 4 °C. CT 
DNA was solubilized in ddH2O at about 1 mM with gen-
tle mixing during 1 week at 4 °C. The solution was then 
filtered, stored at 4 °C, and used within 6 months. DNA 
concentration was determined via UV–Vis spectroscopy 
using extinction coefficients provided by the manufactur-
ers and listed in Table 1. The following buffers were used 
in this study: 10 mM lithium cacodylate, pH 7.2, 5 mM 
KCl, 95 mM LiCl (5K); 10 mM lithium cacodylate, pH 7.2, 
50 mM NaCl, 50 mM LiCl (50Na); 10 mM KPi, pH 7.0, 
50 mM KCl (KPi).
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UV–Vis studies
A Cary 300 Varian spectrophotometer with a Peltier-ther-
mostated cuvette holder (error of ±0.3 °C) or UVIKON 
XL or XS spectrophotometers were used for all UV–Vis 
studies. Samples were prepared in 1 cm quartz cuvettes 
or in 1 cm methacrylate cuvettes; the latter were used 
to minimize porphyrin adsorption to the surface of a 
cuvette.
Aggregation studies
UV–Vis spectra were collected as a function of porphyrin 
concentration in the spectral window of 350–450 nm in 
water for PtTMPyP4 (0.5–20 µM range) and in 5K buffer 
for PdTMPyP4 (0.5–50 µM range).
Titrations of PtTMPyP4 and PdTMPyP4 with Tel22 in 5K 
buffer
Titrations were performed by stepwise additions of Tel22 
to a solution of 1–6 µM PtTMPyP4 or ~3 µM PdTMPyP4 
in 5K buffer. Solution of Tel22 was added to a cuvette with 
porphyrin, mixed thoroughly and equilibrated for two min 
after which UV–Vis spectra were acquired in 350–650 nm 
range. Titration was deemed complete when the spectra 
collected after three successive additions of Tel22 were 
nearly superimposable. Data were treated as described in 
our earlier work [36]. Additionally, the spectra were cor-
rected for dilution effect. Both direct fitting of UV–Vis data 
(assuming two-state equilibrium) and Scatchard analysis 
were used to obtain the values of binding affinity and stoi-
chiometry. Hypochromicity (% H, decrease in signal inten-
sity) and red shift (change in peak position) were extracted 
from UV–Vis data. PtTMPyP4 titrations were also carried 
out in KPi buffer, and the results are presented in Supple-
mentary Material. Titrations were done in triplicate.
Continuous variation analysis: Job’s plot [45]
Solutions of PtTMPyP4 and of Tel22 were prepared in 5K 
buffer at equal concentrations of ~3 µM. Two sets of exper-
iments were completed. In the first one, samples of PtT-
MPyP4 were placed in the sample and in the reference cells 
of UV–Vis spectrophotometer and were titrated with Tel22 
(sample cell) and with 5K buffer (reference cell) in iden-
tical manner. In the second set of experiments, a solution 
of Tel22 was placed in the sample cell and a solution of 
5K was placed in the reference cell; both cells were titrated 
with PtTMPyP4 solution. The difference spectra were col-
lected in 350–670 nm range. Job plots were constructed by 
plotting the absorbance at selected wavelengths (where the 
largest change was observed) vs. mole fraction of the por-
phyrin (range 0–1). Minima or maxima on Job plots report 
Table 1  Oligonucleotide sequences, extinction coefficients and fluorescence enhancement data
a Fluorescence enhancement is defined as a ratio of the fluorescence of PtTMPyP4 in the complex with the specified DNA to the fluorescence of 
the porphyrin alone
b 5K buffer was used for fluorescence enhancement studies unless stated otherwise
Name Sequence 5′ → 3′ ɛ260, mM−1 cm−1 Fluorescence enhancementa,b
F21D 5′-6-FAM-GGG(TTAGGG)3-Dabcyl-3′ 247.6 N/A
CT Genomic calf thymus DNA 12.2 (per bp) 22.3 ± 0.6
17A CCAGTTCGTAGTAACCC 160.9 38.1 ± 1.5
17B GGGTTACTACGAACTGG 167.4 43.9 ± 3.0
17AB Duplex formed by 17A and 17B oligonucleotides 328.3 46.0 ± 0.7
ds26 CAATCGGATCGAATTCGATCCGATTG 253.2 39.1 ± 5.2
Tel22 AGGGTTAGGGTTAGGGTTAGGG 228.5 54.2 ± 14.6 (50Na buffer)
71.8 ± 10
VEGF GGGAGGGTTGGGGTGGG 171.4 76.9 ± 3.8
cMyc TGAGGGTGGGTAGGGTGGGTAA 228.7 28.0 ± 5.0
26TelG4 AGGGGTTAGGGGTTAGGGGTTAGGGG 268.9 54.1 ± 15 (50Na buffer)
65.4 ± 4.8
Bcl-2 GGGCGCGGGAGGGAATTGGGCGGG 237.4 39.2 ± 5.7
cKit1 GGGAGGGCGCTGGGAGGAGGG 213.2 28.0 ± 5.6
G4TERT AGGGGAGGGGCTGGGAGGGC 202.9 85.7 ± 0.9
TBA GGTTGGTGTGGTTGG 143.3 32.6 ± 6.8 (50Na buffer)
29.5 ± 5.4
G4T4G4 GGGGTTTTGGGG 115.2 40.5 ± 12 (50Na buffer)
42.2 ± 9.2
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on binding stoichiometry. Similar experiments were also 
completed in KPi buffer (see Supplementary Material).
Fluorescence studies
Resonance light scattering (RLS)
RLS method allows us to study aggregation of chromophores 
using a conventional fluorimeter [46], a Spex Fluorolog-3 
(HORIBA Jobin–Yvon, France) in our case. A solution 
of 2.5 mL of 5.1 µM PtTMPyP4 in KPi was titrated with 
120 µM Tel22 (which also contained 5.1 µM PtTMPyP4 to 
avoid porphyrin dilutions) at 25 °C in a 1 cm cuvette. Time 
scans were collected first to determine the amount of time 
required for signal stabilization (~15 min). The following 
parameters were used for the time scans: a time increment 
of 2 s, an integration time of 1 s and slit widths of 1 nm for 
both excitation and emission. After signal stabilization (for 
15 min), synchronous scans were collected with the fol-
lowing parameters: excitation at 460 nm, emission range of 
300–600 nm, offset of 0 nm, increment of 0.5 nm, averaging 
time of 0.5 s, number of scans 2 (averaged), and 1 nm slits 
both for excitation and emission. Before each new addition 
of Tel22, the UV–Vis spectra were also collected.
Fluorescence titrations
Fluorescence titrations were performed on a Photon Tech-
nology International QuantaMaster 40 spectrofluorimeter. 
A 2.0 mL solution of 1.7–2.0 µM PtTMPyP4 in 5K buffer 
was titrated with 60–100 µM of either Tel22 or CT DNA in 
a 1 cm methacrylate cuvettes with four transparent windows. 
After addition of DNA, the solution was thoroughly mixed, 
equilibrated for 30 s and emission scans were collected with 
the following parameters: excitation at 412 nm, emission 
range of 600–800 nm, increment of 1 nm, integration time of 
0.5 s, slit of 5 nm each, and temperature of 20 °C. DNA was 
added until no further increase of fluorescence was observed.
Light‑switch effect of PtTMPyP4 in the presence of a 
variety of DNA secondary structures
These experiments were carried out in triplicate in 96-well 
plates (Greiner Bio-one; 96-well, black, flat bottom) at 
25 °C using Tecan Infinite M1000 PRO microplate reader. 
Every replicate contained a 50 µL of 0.11 µM solution of 
PtTMPyP4 to which 5 µL of 55 µM DNA was added; final 
DNA to porphyrin ratio was 50:1 to ensure that all por-
phyrin was saturated with DNA. The plate was stirred for 
30 s and briefly centrifuged. Fluorescence emission was 
then recorded with the excitation wavelength set at 412 nm 
and the emission wavelength at 670 nm. Fluorescence 
enhancement was calculated as a ratio of fluorescence of 
PtTMPyP4/DNA mixture to the fluorescence of PtTMPyP4 
alone. The DNA sequences used in this experiment are 
listed in Table 1.
Pt–Pt charge transfer band by fluorescence
A 3D excitation/emission fluorescence scan was per-
formed on a sample containing 5.0 µM Tel22 and 30 µM 
PtTMPyP4 in 5K buffer. The 3D surface was built using 
individual emission scans in the range from 700 to 850 nm 
with excitation wavelength dimension covering the range 
from 500 to 680 nm (2 nm bandwidth).
Fluorescent resonance energy transfer melting studies, 
FRET
FRET studies were performed according to a well estab-
lished protocol [47] using fluorescently labeled human 
telomeric DNA (F21D) in 5K buffer. CT DNA, a duplex 
competitor, was used in competition experiments, and unla-
beled Tel22 was used as a control to assure that observed 
fluorescent changes are not due to contribution from the 
porphyrin. The specific experimental details and data treat-
ment methods are described in our earlier work [36].
Circular dichroism
Circular dichroism (CD) experiments were performed on 
either a Jasco J-800 or AVIV 410 spectropolarimeters con-
taining a Peltier heating unit (error of ±0.3 °C) with a 1 cm 
quartz cuvette. On Jasco J-800, scans were collected at 
100 nm/min rate, 1 nm increment, 1 s response time. Each 
final spectrum was obtained by averaging three scans, sub-
tracting the spectrum of a buffer, and smoothing the data 
using a Savitzky–Golay function. Additional details can be 
found elsewhere [36].
CD annealing experiments
Solutions of Tel22, c-myc, or G4TERT at 2.5 µM were 
annealed either alone or with 5.0 µM PtTMPyP4 in 5K buffer, 
allowed to cool to room temperature, and equilibrated at 4 °C 
overnight. CD scans were then collected as described above.
CD titration experiments
A 2 µM solution of annealed quadruplex DNA was titrated 
with an increasing amount of PtTMPyP4 at 4 °C. After 
each addition of porphyrin, solution was thoroughly mixed 
and incubated for 3 min after which CD spectrum was col-
lected and treated as describe above. PtTMPyP4 was added 
up to 4 equivalents. All data in this work were processed 
with Origin 9.0 software.
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Results and discussion
In this work, we investigated how Pt(II) and Pd(II) meta-
lation of the widely studied quadruplex ligand TMPyP4 
affects its interaction with quadruplex DNA from telomeres 
and oncogene promoters. In both porphyrins, PtTMPyP4 
and PdTMPyP4, metal centers are expected to be four 
coordinate square planar without axial ligands and, thus, 
suitable for interaction with a terminal G-tetrad of a quad-
ruplex. Under our experimental conditions, both porphyrins 
exist in a monomeric form (Figure S1), which simplifies 
our biochemical studies.
Porphyrin‑Tel22 binding explored through UV–Vis 
titrations
UV–Vis titrations provide a convenient way to quantita-
tively characterize GQ–porphyrin interactions. Specifi-
cally, binding mode, stoichiometry, and binding constants 
can be determined via analysis of UV–Vis titration data. 
Representative UV–Vis titrations for Pt- and PdTMPyP4 
are shown in Fig. 2 and in SI Figure S2, respectively. 
Hypochromicities were determined to be 53 ± 1 % and 
45 ± 2 %, and red shifts were determined to be 13.5 ± 0.5 
and 14 ± 1 nm for Pt- and PdTMPyP4, respectively. Simi-
lar values of red shift and hypochromicity were reported 
for Pt- and PdTMPyP4 binding to plasmid DNA (B-form 
pBluescript II plasmid) [48]. These high numbers might 
suggest intercalation as the possible binding mode based 
on extensive studies of porphyrin intercalation into duplex 
DNA [43]. However, this binding mode, although sug-
gested by dynamic molecular modeling simulations [49], 
has not been observed experimentally. In structural stud-
ies, porphyrins bind to external G-tetrads (end-stacking) 
[20], loops, or to base-pairs [50], but do not intercalate. 
Regardless of the exact mode of binding, high values of 
hypochromicity and red shift indicate strong stacking inter-
actions between the porphyrin and the DNA bases, which 
then perturb the electronic distribution around porphyrin 
ring. Loop or groove binding, most likely, would not pro-
duce such large changes in UV–Vis spectra, suggesting 
end-stacking as a binding mode.
To extract binding affinities and stoichiometries, UV–
Vis data were subjected to a Direct Fit, which is based 
on the two-state equilibrium between free and quad-
ruplex-bound porphyrin [36], and a Scatchard analy-
sis, developed for a ligand bound to a long polyanionic 
DNA (notably duplex DNA). Because a quadruplex can-
not be truly approximated as a long DNA, the results of 
Scatchard treatment need to be interpreted with caution 
and should be only used in conjunction with other data 
analyses. According to both models, if multiple binding 
sites exist on the DNA these binding sites are equiva-
lent and non-cooperative. In other words, it is assumed 
that there is no preference of the porphyrin to one Tel22 
binding site over another, and that the binding of one por-
phyrin does not affect the binding of a subsequent mol-
ecule. Thus, the binding ratios represent the total number 
of porphyrins bound and binding constants reflect all the 
binding events. Direct Fit of the data yielded a binding 
affinity of (5.8 ± 0.8) × 106 M−1 for PtTMPyP4 when 
the binding stoichiometry was fixed at 7:1 porphyrin-to-
DNA and (1.0 ± 0.3) × 107 M−1 for PdTMPyP4 when 
the binding stoichiometry was fixed at 6.5 (Figs. 2c, S2c). 
Using Scatchard analysis of titration data for PtTMPyP4 
we obtained a stoichiometry of 6.7 ± 0.5 and a binding 
affinity of (9.2 ± 0.1) × 106 M−1; the same numbers for 
PdTMPyP4 are 6.5 ± 0.5 and (0.78 ± 0.03) × 107 M−1. 
Both Direct Fits and Scatchard analyses are in excellent 
agreement with each other.
Fig. 2  Titration of PtTMPyP4 with Tel22 in 5K buffer at 20 °C. a 
Representative UV–Vis absorption spectra of 1.1 μM PtTMPyP4 
titrated with 22.0 μM Tel22. The final [GQ]/[PtTMPyP4] ratio was 
0.93. b A representative Job plot constructed by plotting the differ-
ence in the absorbance values at 399 nm versus mole fraction of PtT-
MPyP4. The data from two titrations are shown starting with either 
DNA (solid symbols) or porphyrin (open symbols). c Direct fit of the 
titration data at specified wavelengths. Binding constant was deter-
mined to be (5.8 ± 0.8) × 106 M−1 with a binding ratio of 7:1 por-
phyrin-to-GQ based on two independent experiments. Dashed lines 
represent 95 % confidence interval
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UV–Vis titration experiments were also conducted in 
KPi buffer, Figure S3, yielding 13.8 ± 0.3 nm red shift 
and 45 ± 2 % hypochromicity, values similar to those 
reported above for 5K buffer. Scatchard and Direct Fit 
analyses yielded ~7:1 porphyrin-to-DNA binding stoichi-
ometry and (1–3) × 108 M−1 binding affinity, higher as 
compared to the values in 5K buffer. This apparent dis-
crepancy could be explained by the difference in ionic 
strength between KPi buffer (~60 mM) and 5K buffer 
(110 mM). Usually, increase in the ionic strength leads to 
weakening of interactions especially those with signifi-
cant electrostatic component as is expected from quad-
ruplex binding to PtTMPyP4 ligand that has 4+ positive 
charge.
Observed binding stoichiometry was also measured 
in the model independent Continuous Variation Analysis 
method, also known as Job plot method [45]. By keeping 
the total concentration of porphyrin and DNA constant 
and, at the same time, varying the mole fraction of the 
porphyrin and DNA, the binding ratio can be determined 
from the difference in absorbance as shown in Fig. 2b for 
5K buffer and Figure S4 for KPi buffer. Job’s method is 
effective in identifying the binding ratio in a non-coop-
erative system as well as the overall binding ratio. With 
high enough resolution, other equilibria and their binding 
ratios can also be identified. Job plot analysis of the data 
using 399 nm wavelength yielded binding stoichiom-
etry of 4:1 PtTMPyP4:Tel22. Interestingly and reproduc-
ibly, the data from the same Job plot titration at 425 nm 
(absorption maximum of a PtTMPyP4-Tel22 complex) 
yielded binding stoichiometry of only 2:1. In both cases, 
binding stoichiometry is lower than that obtained from 
the Direct Fit or Scatchard analysis of UV–Vis titrations. 
Our data can be reconciled by a model where 2–4 mol-
ecules of PtTMPyP4 bind Tel22 with high affinity, fol-
lowing by additional weaker binding of another 3–4 por-
phyrins. This second step could signify (1) binding of 
porphyrins to additional binding sites on Tel22, which 
is rather difficult to imagine; (2) non-specific binding 
between negatively charged DNA and positively charged 
porphyrin molecule; yet, reproducible binding stoichiom-
etry argues against this case; or (3) stacking of additional 
porphyrins onto already bound porphyrin molecules 
(aggregation).
To test this latter possibility, we searched for MMLCT, 
metal–metal-to-ligand-charge transfer bands (usually in 
the near-infrared region of >700 nm) [51, 52] between 
Pt(II) ions in the stacked porphyrin complexes. While the 
MMLCT band was not observed, stacking of porphyrins 
without direct and close Pt–Pt interaction is still possible in 
a manner allowing for an efficient overlap of their aromatic 
systems. The presence of porphyrin aggregates was further 
investigated in resonance light scattering experiments.
Resonance light scattering (RLS)
RLS identifies the presence of supramolecular assemblies 
by detecting the amount of light scattered by them [46]. 
RLS takes advantage of the enhanced Rayleigh scatter-
ing of porphyrins near their absorption maximum (Soret 
band) in aggregated state. It is important to note that, 
unlike UV–Vis and fluorescence titrations (see below), 
RLS is performed under conditions of porphyrin excess. 
A ~5 µM solution of PtTMPyP4 was excited at 460 nm, 
and the scattering was measured at the same wavelength. 
In the absence of Tel22, PtTMPyP4 does not aggregate, 
which is in agreement with our UV–Vis aggregation stud-
ies (Figure S1). However, addition of Tel22 leads to aggre-
gate formation, but only at low [Tel22]/[PtTMPyP4] ratios 
(Fig. 3). Specifically, aggregate size grows (as judged by 
the scattering intensity) and reaches maximum at [Tel22]/
[PtTMPyP4] = 0.12, then aggregates decrease in size and 
disappear at [Tel22]/[PtTMPyP4] > 0.5. The RLS data sug-
gest that the largest aggregates of PtTMPyP4-Tel22 con-
tain ~8 molecules of PtTMPyP4 per each Tel22 molecule. 
When more DNA is available, these aggregates dissolve. 
The observed [PtTMPyP4]/[Tel22] ratio of 8 is in agree-
ment with Scatchard analysis of UV–Vis titration data and 
the Direct Fit model suggesting 7:1 stoichiometry. Combin-
ing RLS and UV–vis data, we can propose the following 
binding mode for PtTMPyP4 and Tel22. PtTMPyP4 origi-
nally end-stacks onto Tel22 and, in the absence of sufficient 
Tel22 molecules, additional porphyrin molecules aggregate 
with each other stacking on the top of the already bound 
PtTMPyP4. Once more Tel22 becomes available, these 
aggregated dissolve and completely disappear at [Tel22]/
Fig. 3  Resonance light scattering titration of PtTMPyP4 with Tel22. 
A solution of PtTMPyP4 at 5.1 µM in KPi buffer was titrated with 
120 µM solution of Tel22 at 20 °C
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[PtTMPyP4] > 0.5. Note, most of the experiments in this 
paper were performed at [Tel22]/[PtTMPyP4] > 0.5 where 
no aggregation was observed.
Porphyrin‑Tel22 binding and selectivity explored 
through fluorescence titrations
PtTMPyP4 fluoresces weakly alone. Addition of a quad-
ruplex DNA leads to a significant increase in PtTMPyP4 
fluorescence, which was used to further investigate bind-
ing between PtTMPyP4 and human telomeric DNA. A 
representative titration of PtTMPyP4 with Tel22 is shown 
in Fig. 4a. The data were analyzed using Direct Fit apply-
ing different binding models (5:1, 6:1, 7:1, etc.) with the 
best fit obtained for 7:1 PtTMPyP4 to Tel22 binding. The 
binding constant obtained, (1.8 ± 0.3) × 106 M−1 and the 
stoichiometry are in good agreement with the data from 
UV–Vis titrations.
In order to determine the extent to which the porphy-
rin is selective for GQ over duplex DNA, PtTMPyP4 was 
also titrated with CT DNA under conditions identical to 
those used for Tel22. The results, shown in Fig. 4b, indi-
cate that the fluorescence of PtTMPyP4 increases in the 
presence of CT DNA but to a substantially lower extent 
as compared to Tel22. Data fitting result in a 1:1 binding 
model and a binding constant of (1.1 ± 0.5) × 106 M−1 
per base-pair in CT DNA. It is important to point out that 
while the concentration of Tel22 is measured per DNA 
strand (22 nt), concentration of CT DNA is expressed per 
base-pair.
Fig. 4  Fluorescent titration of PtTMPyP4 with DNA in 5K buffer 
at 20 °C. a, b Representative fluorescence titrations spectra for PtT-
MPyP4 upon addition of Tel22 and CT DNA. c, d Increase in fluores-
cence signal intensity at 671 nm as a function of DNA concentration 
and corresponding data fit for Tel22 and for CT DNA. Concentration 
of binding sites corresponds to concentration of DNA multiplied by 
the binding stoichiometry. Dashed lines represent 95 % confidence 
interval
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Binding constants and stoichiometry of binding deter-
mined for PtTMPyP4 and for PdTMPyP4 in 5K buffer 
are comparable to the binding constants reported for 
TMPyP4 or its other metallated analogues. Literature 
binding constants for TMPyP4 vary greatly within at 
least three orders of magnitude and the stoichiometry 
varies between 2 and 4 depending on the DNA sequence, 
buffer composition, and experimental method used [39, 
49, 53]. For example, binding of TMPyP4 and its Ni(II) 
derivative to human telomeric DNA is characterized by 
Ka of ~10
6 M−1; binding of Mn(III)TMPyP4 is an order 
of magnitude stronger with Ka of ~10
7 M−1 (all meas-
ured via SPR). The latter porphyrin was also shown to be 
the most selective of the three [40]. Binding of TMPyP4 
to Tel22 in 150 mM K+ buffer was described using 
three binding events with two strong binding constants, 
K1 = 7 × 108, K2 = 6 × 107, and K3 = 4 × 104 M−1 
[39]; the binding parameters were measured via ITC. In 
the same study binding of Cu(II)-, Ni(II)-, Co(III)- and 
ZnTMPyP4 was also characterized. The first two com-
plexes display two binding events and strong binding 
with Ka (CuTMPyP4) = 2 × 1010 M−1, and Ka (NiT-
MPyP4) = 7 × 107 M−1 for the strongest binding event. 
Binding of ZnTMPyP4 is weaker with Ka = 8 × 105 M−1 
and binding of Co(III)TMPyP4 to Tel22 is weak with 
Ka  = 1 × 105 M−1 most likely due to the presence of 
axial water ligands in these two complexes [39]. Cu(II)
TMPyP4 binds to parallel tetrastranded quadruplexes 
[dT4G4T4]4 and [dT4G8T4]4 with Ka of (0.1–5) × 107 M−1 
depending on the model used [35]. Finally, ZnTMPyP4 
binds to a bimolecular [(dTAGGG)2]2 quadruplex with 
binding stoichiometry of 2 and Ka of 6 × 106 M−1 (from 
UV–Vis titrations) [36]; ZnTMPyP4 also was reported 
to bind to Pb2+-induced Tel22 quadruplex with binding 
stoichiometry of 2; Ka was not reported [54]. Overall, 
TMPyP4 and its metallated derivatives (including Pt- and 
PdTMPyP4) display strong binding to human telomeric 
DNA. While every study agrees on the end-stacking as 
the most efficient binding mode with high value of Ka, 
the high stoichiometry is usually explained by additional 
binding modes. Lewis, et al. suggest intercalation [39]; 
while our values of hypochromicity and red shift as well 
as the presence of CD-induced signal (see below) could 
be interpreted as the result of intercalation, this binding 
mode is not favored in the quadruplex field as it has never 
been observed experimentally in any structural studies. 
Groove binding was suggested in another report [40] and 
was used also to explain the unusually high selectivity of 
Mn(III)TMPyP4.
Stabilizing properties of PtTMPyP4 and PdTMPyP4 
and selectivity toward Tel22 assessed through FRET
Fluorescent energy resonance transfer (FRET) assay is a 
benchmark technique in the quadruplex field to probe the 
stability and selectivity of quadruplex ligands [55]. To 
ascertain the stabilizing capabilities of Pt- and PdTMPyP4 
toward the human telomeric quadruplex, we used its fluo-
rescently labeled version, F21D. In K+ buffer, F21D forms 
a hybrid intramolecular GQ and in 50Na buffer F21D 
forms an antiparallel GQ, just like its unlabeled counter-
part, Tel22. The secondary structure of F21D was con-
firmed by CD and thermal denaturation studies (TDS), 
and both signatures were similar to those for Tel22 [56]. In 
FRET, the stability of F21D (0.2 µM) is measured in the 
presence of increasing amounts of ligand and the data are 
usually reported in the form of ΔTm, the change in melting 
temperature for DNA–ligand complex as compared to Tm 
of DNA alone.
In a conventional FRET setup, up to 20-fold ligand is 
added to DNA, but in our case, this amount of ligand led 
to melting curves with fluorescence values below 0.5 at the 
maximum temperature of 95 °C (Figure S5), suggesting 
incomplete quadruplex melting (ligand-stabilized GQ has 
a Tm > 95 °C). Therefore, the experiments were repeated 
with a reduced amount of porphyrins, only up to 3 equiva-
lents, Fig. 5a. Observed stabilization temperatures, ΔTm, 
are 30.7 ± 0.6 °C for PtTMPyP4 and 30.9 ± 0.4 °C for 
PdTMPyP4 in 5K at 0.4 μM ligand (2:1 porphyrin-to-GQ). 
Both Pt- and PdTMPyP4 stabilize F21D more strongly 
than TMPyP4, CuTMPyP4, ZnTMPyP4 [36] and N-methyl 
mesoporphyrin IX (NMM) [56]. In order to ensure that the 
observed increase in fluorescence with increased tempera-
ture is due to unfolding of the fluorescently labeled quad-
ruplex and not due to the natural fluorescence of the disso-
ciated metalloporphyrin, FRET experiments were repeated 
using non-fluorescent DNA, Tel22, instead of F21D (Fig-
ure S6), and showed the baseline fluorescence only.
FRET experiments conducted in the presence of DNA 
competitor can provide information about ligands selectiv-
ity for GQ vs. other DNA structure. Because duplex DNA 
is present in excess in the cell, double-stranded calf thymus 
DNA was selected as the competitor. Selectivity for GQ is 
determined by finding the melting temperature of a GQ-
forming sequence in the presence of increasing concentra-
tions of unlabeled CT DNA at fixed concentration of ligand. 
Ligands selective for GQ DNA should bind to the GQ in 
the presence of the competitor as strongly as they bind to 
GQ alone. Thus, unchanging Tm observed with increasing 
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CT DNA concentration is consistent with excellent selec-
tivity. Our results, Fig. 5b, show that the stabilization tem-
perature of F21D in the presence of 1 equivalent of porphy-
rins decreases upon the addition of up to 480 fold excess 
of CT DNA, indicating that both porphyrins are only mod-
estly selective for quadruplex vs. duplex DNA. To quantify 
the selectivity, we used the selectivity ratio, defined as the 
excess of competitor necessary for a 50 % decrease in the 
observed stabilization temperature. Pt- and PdTMPyP4 
display selectivity ratios of 150 and 330, respectively, in 
5K. These value are similar to those obtained for TMPyP4 
(selectivity ratio of 300) and ZnTMPyP4 (selectivity ratio 
of 100) [36], but much lower than that of NMM (high 
selectivity ratio, well above 480) [56]. Modest selectivity 
of tetracationic porphyrins (TMPyP4, Zn-, Pt- and PdT-
MPyP4) is most likely a result of the strong electrostatic 
interactions between the 4+ charged porphyrin and nega-
tively charged DNA (whether it is quadruplex, duplex or 
other DNA topology, also see below). Overall, FRET stud-
ies suggest that Pt- and PdTMPyP4 are extremely robust 
and moderately selective stabilizers of mixed-hybrid F21D 
quadruplex in K+ condition.
‘Light‑switch’ effect of PtTMPyP4 in the presence of a 
variety of DNA structures
Fluorescent titration studies, discussed earlier, made use 
of ‘light-switch’ property of PtTMPyP4 whose emission 
increases significantly upon binding to DNA [48]. Fluo-
rescence enhancement is an ideal method to investigate 
the selectivity of PtTMPyP4 toward a variety of DNA sec-
ondary structures. Our laboratory has used this method to 
demonstrate an excellent selectivity of another porphyrin, 
NMM, toward quadruplexes [57]. Here we tested the effect 
of single-stranded DNA (17A, 17B), duplex DNA (CT 
DNA, ds26, 17AB) and quadruplex DNA (oncogene pro-
moters: Bcl-2, cMyc, cKit1, VEGF, G4TERT; and telomeric 
DNA: Tel22, 26TelG4, G4T4G4) on fluorescence of PtT-
MPyP4. The list of all the DNA sequences can be found in 
Table 1. For quadruplexes, the experiments were conducted 
both in K+ buffer, in which quadruplexes are usually (but 
not always) parallel, and in Na+ buffer, in which an antipar-
allel geometry is expected. The results (Fig. 6; Table 1) 
demonstrate that PtTMPyP4 displays ‘light-switch’ effect 
in the presence of all DNA secondary structures. Overall 
and on average, the fluorescence enhancement is the highest 
in the presence of quadruplexes, notably VEGF, G4TERT 
and telomeric DNA (Tel22 and 26TelG4). PtTMPyP4 does 
not differentiate between different quadruplex folds, as we 
observed earlier with NMM [57]. In summary, PtTMPyP4 
displays a moderate selectivity for quadruplex DNA vs. 
other DNA structures as was already shown in FRET assay 
(see above). This is the most comprehensive study of ‘light-
switch’ effect displayed by PtTMPyP4 in the presence of a 
wide variety of DNA secondary structure. This study sug-
gests broad selectivity for PtTMPyP4.
PtTMPyP4–Tel22 binding interactions probed 
by circular dichroism
To determine if PtTMPyP4 affects the topology of a quadru-
plex, CD titration and annealing experiments were performed 
using three representative quadruplexes: cMyc in 5K (parallel 
topology), Tel22 in 5K (mixed-hybrid topology) and Tel22 in 
50Na (antiparallel topology). The cMyc oncogene promoter 
is a transcriptional regulator, overexpressed in up to 80 % of 
solid tumors [3]. This DNA displays the typical parallel quad-
ruplex CD signature with a peak at 265 nm and a trough at 
Fig. 5  Stabilizing ability and selectivity of Pt- and PdTMPyP4 via 
FRET in 5K buffer. a Increase in the stabilization temperature of 
0.2 µM F21D as a function of porphyrin concentration. b Selectivity 
of Pt- and PdTMPyP4 toward F21D in the presence of duplex com-
petitor, CT DNA, amount of which is specified in the legend. Porphy-
rins and F21D were used at 0.2 μM in the selectivity experiments
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Fig. 6  PtTMPyP4 fluoresces 
in the presence of a variety of 
DNA secondary structures. 
Fluorescence enhancement 
is determined relative to the 
fluorescence of PtTMPyP4 
alone. The DNA-to-porphyrin 
ratio is 50:1 for all DNA except 
for CT, for which it is 500:1 
and 5000:1. The buffer used is 
indicated in parentheses next to 
the name of the DNA sequence
Fig. 7  PtTMPyP4 reduces CD signal of DNA quadruplexes. a Rep-
resentative titration of 2 µM Tel22 in 5K buffer; b representative titra-
tion of 2 µM cMyc in 5K buffer, and c representative titration of 2 µM 
Tel22 in 50Na buffer. d Induced CD signal in the porphyrin Soret 
band at 410 nm in the CD spectrum of Tel22 in 50Na buffer upon 
addition of 4 equivalents of PtTMPyP4 (same as the green line in part 
c)
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244 nm. In 5K buffer, human telomeric DNA, Tel22, displays 
peaks at 294 and 255 nm and a trough at 235 nm, a signal 
consistent with the mixed-hybrid structure [17, 58]. The CD 
of Tel22 in 50Na buffer consists of a peak at 294 nm and a 
trough at 260 nm, which is a typical signature of an antipar-
allel GQ. In all cases and indiscriminately, addition of PtT-
MPyP4 preserves the overall CD signature but leads to a 
decrease in CD signal intensity (Fig. 7). Signal decrease 
is concentration dependent. Similar decrease in CD signal 
intensity was observed upon titration of Tel22 in K+ and in 
Na+ buffers with TMPyP4 and its Cu(II)- and Ni(II)-deriva-
tives. On contrary, when Co(III)TMPyP4 or Zn(II)TMPyP4 
were added to Tel22, its CD signal did not change [39]. The 
decrease in CD signal intensity could be due to the prefer-
ential interaction of these porphyrins with single-stranded 
DNA as well as to the partial precipitation of DNA at high 
porphyrin/DNA ratios. It is conceivable that PtTMPyP4 could 
replace (unfold) one of the tetrads, leading to decrease in the 
tetrad stacking (hence decrease in CD signal) at the same 
time stabilizing the quadruples (hence higher Tm).
CD titrations are run in the kinetic regime (with fast addi-
tions of the porphyrin), thus, it is possible that insufficient 
time is allowed for a ligand to affect the observed CD sig-
nature. To test the effect of PtTMPyP4 on the three DNA 
topologies under the equilibrium conditions, CD annealing 
experiments were employed: DNA samples were annealed 
in the presence of PtTMPyP4 and equilibrated overnight 
after which the CD scans were collected. The results, shown 
in Figure S7, are consistent with the titration studies, where 
shape of the signals is preserved but the intensity is attenu-
ated. We also checked for the presence of induced CD 
signal, which indicates a strong interaction between DNA 
and the porphyrin. Indeed, negative induced signal was 
observed in the CD spectra of antiparallel Tel22 in the vis-
ible region of CD spectra at ~410 nm (close to PtTMPyP4 
Soret band) upon addition of 4 equivalents of PtTMPyP4 
(Fig. 7d). Negative induced CD signal was also observed 
upon CD titration of B-form pBluescript II plasmid DNA 
with Pt- and PdTMPyP4 [48]. In this latter case, intercala-
tion of the porphyrin into the DNA duplex was used as an 
explanation for the observed induced CD signal. Titration 
of cMyc or Tel22 in 5K with PtTMPyP4 led to no (or very 
weak) induced CD signal. Absence of induced signal in the 
porphyrin’s Soret region of CD spectra does not necessarily 
signify an absence of the interaction between the porphyrin 
and DNA, as NMM was shown to interact with a variety of 
quadruplex structures but displayed no (or weak) induced 
CD signal [59]. Overall, the presence of induced CD signal 
signifies close interaction (involving most probably efficient 
overlap of π–π systems and consistent with end-stacking) 
between the ligand and GQ DNA; absence of induced CD 
signal does not exclude the interaction, but might indicate a 
different binding mode (via loops or grooves).
Concluding remarks
In this work, we investigated the interaction between two 
metallated derivatives of TMPyP4, Pt- and PdTMPyP4, 
and a variety of GQ DNA structures with the main focus 
on human telomeric DNA, Tel22. Via a combination of 
CD, UV–Vis, and FRET studies we were able to demon-
strate that Pt- and PdTMPyP4 interact effectively with GQ 
DNA and stabilize the quadruplex topology. The binding 
mode most probably involves end-stacking on both sides 
of Tel22 with possible additional binding of PtTMPyP4 to 
already bound porphyrin molecules (i.e., aggregation). The 
aggregates dissociate in the presence of additional Tel22. 
Pt- and PdTMPyP4 behave rather similarly toward quadru-
plex DNA, which is not surprising given that both ligands 
adopt similar geometry and both metal centers contain the 
same number of valence electrons (d8) and have similar 
ionic radii, 74 pm and 78 pm for Pt(II) and Pd(II), respec-
tively. PtTMPyP4 has broad selectivity toward DNA and 
its fluorescence can be ‘turned on’ by many DNA struc-
tures including single-stranded DNA, DNA duplex and a 
variety of DNA quadruplexes. Quadruplexes, however, 
lead to the highest fluorescence enhancement. Modest 
selectivity for quadruplex vs. other DNA structures is an 
important flaw in the properties of these molecules, but 
their exceptional stabilizing ability (by >30 °C at 2 equiva-
lents; better that stabilizing ability of TMPyP4) combined 
with high fluorescence enhancement in the presence of 
quadruplex DNA make these molecules valuable quadru-
plex ligands.
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